Literature DB >> 21396410

Use of GFP-expressing influenza viruses for the detection of influenza virus A/H5N1 neutralizing antibodies.

Guus F Rimmelzwaan1, R Joyce Verburgh, Nella J Nieuwkoop, Theo M Bestebroer, Ron A M Fouchier, Albert D M E Osterhaus.   

Abstract

The hemagglutination inhibition (HI) assay is used most commonly for the detection of antibodies to influenza viruses. However, for the detection of antibodies to avian influenza viruses of the H5N1 subtype either induced by infection or by vaccination, the HI assay is insensitive. Therefore, the virus neutralization (VN) assay has become the method of choice to detect human serum antibodies directed to these viruses. However, this assay requires a second assay for the detection of residual virus replication, which makes it laborious to perform and less suitable for high throughput testing of large numbers of samples. Here we describe an alternative method for the detection of these antibodies, which is based on the use of reporter viruses that express the green fluorescent protein (GFP) upon infection of target cells. GFP-expressing viruses were generated carrying the HA of a variety of antigenically distinct H5N1 influenza viruses. The method proved easy to perform and could be carried out rapidly. Using a panel of antisera raised against H5N1 influenza viruses, the assay based on GFP expressing viruses was compared with the classical virus neutralization assay and the hemagglutination inhibition assay. In general, the results obtained in these assays correlated well. It was concluded that the assay based on the reporter viruses is an attractive alternative for the classical virus neutralization assay and suitable for large sero-epidemiological studies or for the assessment of vaccine efficacy in clinical trials.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396410     DOI: 10.1016/j.vaccine.2011.02.082

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Replication-incompetent influenza A viruses that stably express a foreign gene.

Authors:  Makoto Ozawa; Sylvia T Victor; Andrew S Taft; Shinya Yamada; Chengjun Li; Masato Hatta; Subash C Das; Emi Takashita; Satoshi Kakugawa; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2011-08-31       Impact factor: 3.891

2.  Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).

Authors:  Steven F Baker; Aitor Nogales; Felix W Santiago; David J Topham; Luis Martínez-Sobrido
Journal:  Vaccine       Date:  2015-06-01       Impact factor: 3.641

Review 3.  Taming influenza viruses.

Authors:  Makoto Ozawa; Yoshihiro Kawaoka
Journal:  Virus Res       Date:  2011-10-01       Impact factor: 3.303

4.  An improved method for estimating antibody titers in microneutralization assay using green fluorescent protein.

Authors:  Hongmei Yang; Steven F Baker; Mario E González; David J Topham; Luis Martínez-Sobrido; Martin Zand; Jeanne Holden-Wiltse; Hulin Wu
Journal:  J Biopharm Stat       Date:  2015-05-26       Impact factor: 1.051

Review 5.  Development and applications of single-cycle infectious influenza A virus (sciIAV).

Authors:  Aitor Nogales; Steven F Baker; William Domm; Luis Martínez-Sobrido
Journal:  Virus Res       Date:  2015-07-26       Impact factor: 3.303

6.  Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge.

Authors:  Eiko Matsuo; Cristina C P Celma; Mark Boyce; Cyril Viarouge; Corinne Sailleau; Eric Dubois; Emmanuel Bréard; Richard Thiéry; Stéphan Zientara; Polly Roy
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

7.  Rescue of recombinant peste des petits ruminants virus: creation of a GFP-expressing virus and application in rapid virus neutralization test.

Authors:  Qianqian Hu; Weiye Chen; Kehe Huang; Michael D Baron; Zhigao Bu
Journal:  Vet Res       Date:  2012-06-02       Impact factor: 3.683

Review 8.  Novel Approaches for The Development of Live Attenuated Influenza Vaccines.

Authors:  Pilar Blanco-Lobo; Aitor Nogales; Laura Rodríguez; Luis Martínez-Sobrido
Journal:  Viruses       Date:  2019-02-22       Impact factor: 5.048

9.  Optimisations and Challenges Involved in the Creation of Various Bioluminescent and Fluorescent Influenza A Virus Strains for In Vitro and In Vivo Applications.

Authors:  Monique I Spronken; Kirsty R Short; Sander Herfst; Theo M Bestebroer; Vincent P Vaes; Barbara van der Hoeven; Abraham J Koster; Gert-Jan Kremers; Dana P Scott; Alexander P Gultyaev; Erin M Sorell; Miranda de Graaf; Montserrat Bárcena; Guus F Rimmelzwaan; Ron A Fouchier
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.